Journal of Thyroid Disorders & Therapy
Open Access

Department of Surgery, Yamashita Thyroid Hospital, 1-8 Shimogofukumachi, Hakata-ku, Fukuoka City, Japan

Biography

Dr. Hiroshi Takahashi is a distinguished surgeon at Yamashita Thyroid Hospital in Fukuoka City, Japan, specializing in thyroid and parathyroid disorders. His clinical expertise and research contributions have significantly advanced the understanding and management of these conditions. In 2024, Dr. Takahashi co-authored a pivotal study titled "Significant Role of 1,25-Dihydroxyvitamin D on Serum Calcium Levels After Total Thyroidectomy: A Prospective Cohort Study," published in Frontiers in Endocrinology. This research investigated the effects of 1,25-dihydroxyvitamin D on postoperative calcium levels in patients undergoing total thyroidectomy, providing valuable insights into preventing hypocalcemia in this patient population. Another notable publication from 2024 is "Intraoperative Parathyroid Hormone Measurement Pitfalls: Parathyroid Hormone Spikes with Carboxyl-Terminal Parathyroid Hormone Fragments in Primary Hyperparathyroidism—A Case Report," featured in Surgical Case Reports. This case study highlighted challenges in intraoperative parathyroid hormone monitoring due to carboxyl-terminal fragments, emphasizing the need for accurate assessment during surgery for primary hyperparathyroidism. Dr. Takahashi also contributed to the 2024 study "A Prospective Cross-Sectional Study on Hypocalcemia After Total Thyroidectomy in Patients with Graves’ Disease: Insights on Secondary Hyperparathyroidism," published in Surgery Today. This research examined parathyroid function and calcium levels in patients with Graves' disease undergoing total thyroidectomy, offering insights into secondary hyperparathyroidism in this context. Additionally, in 2023, he co-authored "Usefulness of Preoperative Ice Cream Consumption and Novel Postoperative Management for Preventing Chyle Leakage After Neck Surgery," which explored innovative strategies to prevent chyle leakage following neck surgeries.

Publications

• Research Article   
  Changes in Thyroid Stimulating Antibody Levels in Graves' Disease Patients: Methods to Prevent its Increase after Radioactive Iodine Therapy
  Author(s): Seigo Tachibana*, Tomohiro Ohsako, Yusuke Mori, Hisakazu Shindo, Shinya Satoh, Hiroshi Takahashi and Hiroyuki Yamashita
  
  Background: Although it is well-known that thyroid stimulating antibody levels usually increase after radioactive iodine therapy, we observed various changes in thyroid stimulating antibody levels. Methods: We divided 47 patients who underwent radioactive iodine therapy into two groups based on thyroid stimulating antibody levels three months post-therapy, as follows: the D(3M) group with increasing levels and the I(3M) group with decreasing levels of the antibody. We compared the clinical characteristics of the two groups. In addition, the 47 patients were again divided into the following two groups, and their clinical characteristics were compared: the D(6M) and I(6M) groups, which consisted of patients with decreasing and increasing thyroid stimulating antibody levels, respectively, three to six months after radioactive io.. View More»
  DOI: 10.35248/2167-7948.20.9.241

  Abstract HTML PDF

Other relevant publications from this author

• Intraoperative parathyroid hormone measurement pitfalls: parathyroid hormone spikes with carboxyl-terminal parathyroid hormone fragments in primary hyperparathyroidism—a case report

  A prospective cross-sectional study on hypocalcemia after total thyroidectomy in patients with Graves’ disease: insights on secondary hyperparathyroidism

  Usefulness of preoperative ice cream consumption and novel postoperative drainage management in patients undergoing left?sided neck dissection for thyroid cancer: a nonrandomized prospective study